About Bibhash Mukhopadhyay
Form D filings for NephroDI Therapeutics in 2024 list Bibhash Mukhopadhyay as director.
Bibhash Mukhopadhyay first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Bibhash Mukhopadhyay in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Bibhash Mukhopadhyay works with at each company, as listed on that company's latest Form D.
NephroDI Therapeutics, Inc. · Form D, Jun 18, 2024
RH
Rachael Hagan
President and director
MG
Michael Grissinger
Director
JD
Jeff Sands, M.D.
Executive officer